Janney Montgomery Scott LLC Ultragenyx Pharmaceutical Inc. Transaction History

Janney Montgomery Scott LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 29, 2019	SELL	$42.5 - $63.11 $191,717 - $284,689	-4,511 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$54.93 - $74.36 $28,288 - $38,295	515 Added 12.89%	4,511 $286,000
Q1 2019 Apr 30, 2019	BUY	$39.87 - $69.36 $159,320 - $277,162	3,996 New	3,996 $277,000
Q4 2018 Feb 01, 2019	SELL	$38.89 - $77.3 $159,565 - $317,161	-4,103 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$71.81 - $90.15 $294,636 - $369,885	4,103 New	4,103 $313,000

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.8B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.